Monte Rosa Therapeutics, Inc. Share Price
Equities
GLUE
US61225M1027
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 USD | +3.21% | +8.35% | +2.21% |
Sales 2024 * | 6.18M 515M | Sales 2025 * | 5.93M 494M | Capitalization | 282M 23.49B |
---|---|---|---|---|---|
Net income 2024 * | -143M -11.92B | Net income 2025 * | -171M -14.25B | EV / Sales 2024 * | 25.9 x |
Net cash position 2024 * | 122M 10.13B | Net cash position 2025 * | 171M 14.29B | EV / Sales 2025 * | 18.6 x |
P/E ratio 2024 * |
-2.42
x | P/E ratio 2025 * |
-2.41
x | Employees | 133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Monte Rosa Therapeutics, Inc.
1 day | -5.72% | ||
1 week | +2.75% | ||
Current month | +5.26% | ||
1 month | -17.65% | ||
3 months | +18.64% | ||
6 months | +61.38% | ||
Current year | -0.88% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 01/20/01 |
Chief Operating Officer | - | 01/21/01 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 01/20/01 |
Christine Siu
BRD | Director/Board Member | 47 | 01/20/01 |
Chandra Paul Leo
BRD | Director/Board Member | 55 | 01/20/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +5.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 5.775 | +3.12% | 29 489 |
02/24/02 | 5.6 | -5.72% | 176,103 |
01/24/01 | 5.94 | +11.65% | 156,396 |
30/24/30 | 5.32 | -5.17% | 92,522 |
29/24/29 | 5.61 | +5.25% | 89,395 |
Delayed Quote Nasdaq, May 03, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.88% | 282M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.85% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- GLUE Stock